ClinicalTrials.Veeva

Menu

Evaluation of the Ear-EEG System for Sleep Monitoring in Healthy Subjects

University of Aarhus logo

University of Aarhus

Status

Completed

Conditions

Sleep Monitoring

Treatments

Device: ear-EEG

Study type

Interventional

Funder types

Other

Identifiers

NCT03586310
EarEEGSleep2018

Details and patient eligibility

About

Subjects sleep multiple nights in their own home, wearing actigraph, PSG (PolySomnoGraphy) and ear-EEG sensors. The object of the study is to determine the applicability of ear-EEG for sleep monitoring.

Enrollment

20 patients

Sex

All

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Informed consent obtained and letter of authority signed before any study related activities

Age 18-50 years

Exclusion criteria

  1. BMI (body mass index) > 30
  2. Previous stroke or cerebral haemorrhage and any other structural cerebral disease
  3. Known or suspected abuse of alcohol or any other neuro-active substance
  4. Use of hearing aid or cochlear implants
  5. Allergic contact dermatitis caused by metals or generally prone to skin irritation
  6. Narrow or malformed ear canals
  7. Obstructive sleep apnea
  8. History of sleep disorders or neurological diseases
  9. Chronic pain
  10. People judged incapable, by the investigator, of understanding the participant instruction or who are not capable of carrying through the investigation.
  11. Use of medication known to influence the user's sleep (antidepressants, sedatives, antipsychotic-, and pain relieving medication)
  12. Teeth grinding (bruxism)
  13. Pregnancy

Trial design

Primary purpose

Device Feasibility

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 2 patient groups

4 nights with PSG
Other group
Description:
For all subjects: 4 nights with polysomnography and ear-EEG
Treatment:
Device: ear-EEG
12 nights with ear-EEG
Other group
Description:
For a subset of the subjects in arm the '4 nights with PSG', a second phase follows in which each subject sleeps 12 nights with only ear-EEG. If a night's recording is unsuccessful, for whatever reason, up to 6 additional nights may be attempted.
Treatment:
Device: ear-EEG

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems